Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank43
3Y CAGR+4.6%
5Y CAGR-51.4%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+4.6%/yr
vs -6.9%/yr prior
5Y CAGR
-51.4%/yr
Recent acceleration
Acceleration
+11.5pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.50 | -24.6% |
| 2024 | 3.31 | -37.8% |
| 2023 | 5.32 | +144.2% |
| 2022 | 2.18 | -97.2% |
| 2021 | 78.81 | -14.7% |
| 2020 | 92.34 | +1363.3% |
| 2019 | 6.31 | +117.9% |
| 2018 | 2.90 | +52.6% |
| 2017 | 1.90 | -33.2% |
| 2016 | 2.84 | - |